Скачать или смотреть Clinical Conversations for Better T2D Control: GLP-1 Receptor Agonists

Join us for a live social media event on glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) in patients with cardiometabolic disease designed to encourage the exchange of ideas between leaders in the field and attendees.

Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are key agents for the management of people with cardiometabolic disease; they bridge the gap between diabetes care, obesity treatment, and cardiorenal risk reduction. Join this event to hear how GLP-1 RAs can improve outcomes in your patients with type 2 diabetes (T2D). Bring your comments and questions to this engaging and interactive event!

Faculty: Pamela Kushner, MD, FAAFP
Faculty: John E. Anderson, MD

Earn free 0.25 AMA PRA Category 1 Credit™. Access for credit will be shared at the end of this live event.

Click the link to view the Accreditation and Disclosure details before participating:
https://www.medscape.org/s/viewarticl...
2025a1000px0

Supported by an independent educational grant from Novo Nordisk